The electrophysiological and mechanical effects of HNS-32, a novel azulene-1-carboxamidine derivative with antiarrhythmic activity, were studied in isolated guinea-pig myocardial preparations. HNS-32 (10–6–10–4 mol/l) concentration-dependently decreased the maximum rate of rise (Vmax) of action potential in isolated papillary muscle; the potency was the same or slightly higher than that of disopyramide. At 10–4 mol/l, HNS-32 also shortened the action potential duration (APD) and depolarized the resting membrane potential; these effects were similar to those of 10–5 mol/l verapamil. HNS-32 (10–7–10–4 mol/l), as well as verapamil (10–8–10–5 mol/l) and disopyramide (10–6–10–3 mol/l), had concentration-dependent negative chronotropic and negative inotropic effects on isolated right atrial and right ventricular papillary muscle preparations, respectively. The concentration-response relationship for the positive chronotropic effect of isoproterenol was not affected by HNS-32 (10–5 mol/l). In isolated ventricular myocytes, HNS-32 (10–6–10–4 mol/l) concentration-dependently inhibited the peak amplitude of the L-type Ca2+ current. These results suggest that NHS-32 has Vmax reducing activity on myocardial tissue, which may be responsible for antiarrhythmic effect. The drug may also have additional effect on the Ca2+ channel at higher concentrations.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.